Received Apr 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | — | — |
inappropriate reconstitution technique; received only the diluent portion of Menveo; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 16-year-old male patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis. On 30-SEP-2024, the patient received Menveo. On 30-SEP-2024, an unknown time after receiving Menveo, the patient experienced inappropriate preparation of medication (Verbatim: inappropriate reconstitution technique) and inappropriate dose of vaccine administered (Verbatim: received only the diluent portion of Menveo). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK Receipt Date: 31-MAR-2025 The registered nurse reported that a patient received only the diluent portion of Menveo (two vial), which led to an inappropriate dose of vaccine administered and inappropriate preparation of medication. The reporter wanted to know what they need to do.